Institut de Cancérologie de Lorraine
66
4
9
50
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
4.5%
3 terminated/withdrawn out of 66 trials
94.3%
+7.7% vs industry average
5%
3 trials in Phase 3/4
0%
0 of 50 completed trials have results
Key Signals
Enrollment reporting
Analytics
Activity Timeline
Global Presence
Clinical Trials (66)
Efficacy of the MAEva Program (Meditation, Acceptance, and Commitment to Values) Among Patients Treated For Breast Cancer.
Role: lead
Personalized Preventive Support for Cognitive Impairment in Non-Metastatic Breast Cancer (EFACog)
Role: lead
Comparative Study of the Quality of Life of Patients Suffering From OTOTOXICITY Due to Chemotherapy Based on Platinum Salts Fitted With a Hearing Aid Compared to Those Not Fitted.
Role: lead
Impact of Anesthesia Alarm Volume on Mental Workload in Surgical Trainees
Role: lead
Guided Digital Self-Hypnosis Solution for Managing Hot Flashes in Patients Undergoing Adjuvant Hormone Therapy
Role: lead
Brachytherapy (Interventional Radiotherapy) for Squamous Cell Carcinomas of the Nasal Vestibule: Optimization of Dose and Technique
Role: collaborator
Neoadjuvant mFolfirinox With or Without Preoperative Concomitant Chemoradiotherapy in Patients With Borderline Resectable Pancreatic Carcinoma (PANDAS-PRODIGE 44)
Role: lead
Dose Optimization in 3D Pulsed Dose Rate Brachytherapy for Patients With Locally Advanced Cervical Cancer
Role: lead
Detection in Peripheral Blood of Circulating Tumor Cells in Patient With Head and Neck Squamous Cell Carcinoma
Role: lead
Fluorescence for Sentinel Lymph Node Identification in Cancer Surgery
Role: lead
Contribution of Hypnosis to Anxiety and Pain in Brachytherapy Patients
Role: lead
Personalized Circulating DNA Follow-up in Melanoma (PERCIMEL)
Role: lead
Intraoperative Assessment of Surgical Margins Using Confocal Microscopy in Comparison With Reference Extemporaneous Examination
Role: lead
"Mon Parcours de Vie" Localized Breast Cancer: Announcement, Support, Information on the Disease and Treatments. Pilot Study to Assess the Value of Written Information Documents.
Role: lead
Effect of Bladder Distension on Dosimetry in Brachytherapy of Cervical Cancer
Role: lead
Adherence to Oral Therapies in Advanced Breast and Prostate Cancers
Role: lead
Analgesia Nociception Index (ANI) After Unilateral Radical Mastectomy as an Evaluation of Paravertebral Block Failure
Role: lead
Acceptability and Feasibility of a Stress Prevention Program Based on Meditation and Acceptance and Commitment Therapy for Staff at a Cancer Center
Role: lead
Prognostic Value of Measuring CtDNA in a Cohort of Patients With Stage III and IV Upper Aero-digestive Tract (UADT) Cancer , Treated With Curative RADiOtherapy With or Without Concomitant Treatment.
Role: lead
Spinal Palliation in Irradiation for Neoplastic Analgesia and Life Quality
Role: lead